Although many
cancer patients receiving
palliative care experience distressing levels of
fatigue, no well-designed studies have investigated contributing factors in Korean patients. We conducted a cross-sectional study using the Brief
Fatigue Inventory-
K (BFI-K) to measure
fatigue while assessing a variety of possible correlates. Ninety patients with incurable
cancer in the terminal stage (median survival: 27 days) participated in a structured interview and questionnaire related to their medical conditions and underwent blood sampling for laboratory data and
cytokines, including
interleukin (IL)-6 and
tumor necrosis factor (TNF)-α. Body mass index,
dyspnea, the Eastern Cooperative Oncology Group performance status, and levels of
albumin, blood
urea nitrogen (BUN), total
bilirubin, and
C-reactive protein were significantly associated with
fatigue. However, levels of the two proinflammatory
cytokines,
IL-6 and TNF-α, were not significantly correlated with the BFI-K score. In stepwise multiple linear regression,
fatigue was related to elevated BUN (β = 0.376, p = 0.002), severe
pain intensity (β = 0.349, p = 0.004), and impaired performance status (β = 0.268, p = 0.027), but not related to levels of inflammatory
cytokines. In conclusion, the diagnostic work-up and therapeutic plan for patients with
cancer-related
fatigue should include an evaluation of laboratory parameters,
pain severity, and physical performance.